241 related articles for article (PubMed ID: 8406863)
21. Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.
Vallance BA; Deng W; Jacobson K; Finlay BB
Infect Immun; 2003 Jun; 71(6):3443-53. PubMed ID: 12761129
[TBL] [Abstract][Full Text] [Related]
22. The etiology of transmissible murine colonic hyperplasia.
Barthold SW; Coleman GL; Bhatt PN; Osbaldiston GW; Jonas AM
Lab Anim Sci; 1976 Dec; 26(6 Pt 1):889-94. PubMed ID: 1018473
[TBL] [Abstract][Full Text] [Related]
23. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium.
Simmons CP; Clare S; Ghaem-Maghami M; Uren TK; Rankin J; Huett A; Goldin R; Lewis DJ; MacDonald TT; Strugnell RA; Frankel G; Dougan G
Infect Immun; 2003 Sep; 71(9):5077-86. PubMed ID: 12933850
[TBL] [Abstract][Full Text] [Related]
24. Morphogenesis of early 1, 2-dimethylhydrazine-induced lesions and latent period reduction of colon carcinogenesis in mice by a variant of Citrobacter freundii.
Barthold SW; Jonas AM
Cancer Res; 1977 Dec; 37(12):4352-60. PubMed ID: 922726
[TBL] [Abstract][Full Text] [Related]
25. Genetic and biochemical characterization of Citrobacter rodentium sp. nov.
Schauer DB; Zabel BA; Pedraza IF; O'Hara CM; Steigerwalt AG; Brenner DJ
J Clin Microbiol; 1995 Aug; 33(8):2064-8. PubMed ID: 7559949
[TBL] [Abstract][Full Text] [Related]
26. The ultrastructure of transmissible murine colonic hyperplasia.
Johnson E; Barthold SW
Am J Pathol; 1979 Nov; 97(2):291-313. PubMed ID: 525674
[TBL] [Abstract][Full Text] [Related]
27. Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice.
Newman JV; Kosaka T; Sheppard BJ; Fox JG; Schauer DB
J Infect Dis; 2001 Jul; 184(2):227-30. PubMed ID: 11424022
[TBL] [Abstract][Full Text] [Related]
28. Citrobacter rodentium infection causes iNOS-independent intestinal epithelial dysfunction in mice.
Skinn AC; Vergnolle N; Zamuner SR; Wallace JL; Cellars L; MacNaughton WK; Sherman PM
Can J Physiol Pharmacol; 2006 Dec; 84(12):1301-12. PubMed ID: 17487239
[TBL] [Abstract][Full Text] [Related]
29. Citrobacter rodentium espB is necessary for signal transduction and for infection of laboratory mice.
Newman JV; Zabel BA; Jha SS; Schauer DB
Infect Immun; 1999 Nov; 67(11):6019-25. PubMed ID: 10531262
[TBL] [Abstract][Full Text] [Related]
30. CesD2 of enteropathogenic Escherichia coli is a second chaperone for the type III secretion translocator protein EspD.
Neves BC; Mundy R; Petrovska L; Dougan G; Knutton S; Frankel G
Infect Immun; 2003 Apr; 71(4):2130-41. PubMed ID: 12654835
[TBL] [Abstract][Full Text] [Related]
31. Intestinal pathogen or IBD, same T-cell response.
Michetti P
Inflamm Bowel Dis; 2000 Feb; 6(1):63-4. PubMed ID: 10701154
[No Abstract] [Full Text] [Related]
32. Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorrhagic Escherichia coli, Citrobacter freundii, and Hafnia alvei.
Frankel G; Candy DC; Everest P; Dougan G
Infect Immun; 1994 May; 62(5):1835-42. PubMed ID: 8168946
[TBL] [Abstract][Full Text] [Related]
33. Comparison of bacteriological, genetic and pathological characters between Escherichia coli O115a,c:K(B) and Citrobacter rodentium.
Okutani A; Tobe T; Sasakawa C; Nozu R; Gotoh K; Takakura A; Itoh T; Miyamoto Y; Itoh K
Exp Anim; 2001 Apr; 50(2):183-6. PubMed ID: 11381624
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the Citrobacter freundii phoE gene and development of C. freundii-specific oligonucleotides.
Spierings G; Ockhuijsen C; Hofstra H; Tommassen J
FEMS Microbiol Lett; 1992 Dec; 78(2-3):199-204. PubMed ID: 1337052
[TBL] [Abstract][Full Text] [Related]
35. Dietary, bacterial, and host genetic interactions in the pathogenesis of transmissible murine colonic hyperplasia.
Barthold SW; Osbaldiston GW; Jonas AM
Lab Anim Sci; 1977 Dec; 27(6):938-45. PubMed ID: 599885
[TBL] [Abstract][Full Text] [Related]
36. Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice.
Deng W; Vallance BA; Li Y; Puente JL; Finlay BB
Mol Microbiol; 2003 Apr; 48(1):95-115. PubMed ID: 12657048
[TBL] [Abstract][Full Text] [Related]
37. The 3'-terminal half of the btuB gene of Citrobacter freundii defines essential residues and supports a topological model for the outer membrane receptor.
Ward RJ; Glass RE
Mol Microbiol; 1995 May; 16(4):813-5. PubMed ID: 7476175
[No Abstract] [Full Text] [Related]
38. Mutagenesis of conserved tryptophan residues within the receptor-binding domain of intimin: influence on binding activity and virulence.
Reece S; Simmons CP; Fitzhenry RJ; Batchelor M; Hale C; Matthews S; Phillips AD; Dougan G; Frankel G
Microbiology (Reading); 2002 Mar; 148(Pt 3):657-65. PubMed ID: 11882699
[TBL] [Abstract][Full Text] [Related]
39. Fermented dairy products modulate Citrobacter rodentium-induced colonic hyperplasia.
Collins JW; Chervaux C; Raymond B; Derrien M; Brazeilles R; Kosta A; Chambaud I; Crepin VF; Frankel G
J Infect Dis; 2014 Oct; 210(7):1029-41. PubMed ID: 24706936
[TBL] [Abstract][Full Text] [Related]
40. Use of WGS data for investigation of a long-term NDM-1-producing Citrobacter freundii outbreak and secondary in vivo spread of blaNDM-1 to Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca.
Hammerum AM; Hansen F; Nielsen HL; Jakobsen L; Stegger M; Andersen PS; Jensen P; Nielsen TK; Hansen LH; Hasman H; Fuglsang-Damgaard D
J Antimicrob Chemother; 2016 Nov; 71(11):3117-3124. PubMed ID: 27494919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
